CTRI/2019/09/021240尚未招募2 期
Multicentre trial to assess the performance of centralized assay solutions for detection of MTB and resistance to Rifampin and Isoniazid (Protocol Version Number v3.0)
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Aged 18 years or more
- •Clinical suspicion of pulmonary TB including cough >=2 weeks and any other symptom typical of pulmonary TB listed below
- •Recent weight loss
- •Night sweats
- •Contact with active case
- •Haemoptysis
- •Loss of appetite
排除标准
- •Unwilling or unable to provide informed consent
- •Unwilling to provide two sputum specimens at enrolment
- •Patients with only extra-pulmonary TB signs & symptoms
- •Receipt of any dose of TB treatment within 6 months prior to enrolment
研究者
相似试验
尚未招募
不适用
Evaluation of Centralized TB Assay SolutionsCTRI/2022/08/044804Foundation for Innovative New Diagnostics India
进行中（未招募）
1 期
Estudio multicéntrico para evaluar la eficacia de la combinación nifedipino GITS - telmisartan en el control de la presión arterial y otros párámetros: comparación de dos estrategias terapéuticas. - TALENTEUCTR2006-006436-22-ESBayer SpA
招募中
3 期
A trial to evaluate the diagnostic performance of contrast-enhanced ultrasonography in pancreatic mass lesionsPatients with pancreatic mass lesions (pancreatic solid mass or pancreatic cystic mass)pancreatic mass, pancreatic ductal carcinoma, intraductal papillary mucinous neplasmD010190JPRN-jRCT2051220085Kitano Masayuki301
进行中（未招募）
不适用
Prospective, multicenter study to evaluate the renal safety of 6 mg ibandronic acid infusions over 15 min or 60 min in patients with metastatic bone disease due to breast cancer.The target population for this trial are female patients with primary breast cancer with metastatic bone disease.EUCTR2005-000535-18-DERoche Pharma (Schweiz) AG130
已完成
不适用
A multi-centre clinical trial evaluating the safety and functionality of a medical imaging device for tissue review during breast-conserving surgery.Cancer - BreastBreast CancerACTRN12623000205639OncoRes Medical Pty Ltd30